-
admin
Posts
AIM ImmunoTech Regains NYSE American Compliance, Company Resolves Stockholder Equity Deficiency
OCALA, Fla., June 15, 2026 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM,” or the “Company”), an immuno-pharma company focused on the development...
Neumora Therapeutics Reports Data from Phase 3 KOASTAL Program and Provides Business and Pipeline Update
Navacaprant did not achieve the primary endpoint in KOASTAL-2 or -3; Company to discontinue development of navacaprant Advancing potential best-in-class programs with NMRA-511 in Alzheimer’s...
SpyGlass Pharma Appoints Shannon Treviño as General Counsel
ALISO VIEJO, Calif., June 15, 2026 (GLOBE NEWSWIRE) — SpyGlass Pharma, Inc. (Nasdaq: SGP) (SpyGlass Pharma or Company), a late-stage biopharmaceutical company, today announced the...
Porosome Therapeutics Announces Global Drug Development Partnership with the Largest Governmental R&D Organization in India
BOSTON, June 15, 2026 (GLOBE NEWSWIRE) — Porosome Therapeutics, Inc., announced today that it has entered into a drug development partnership with the Council of...
KFSH Highlights Provider Transformation Through Measurable Operational Impact at HLTH Europe 2026
AMSTERDAM, June 15, 2026 (GLOBE NEWSWIRE) — King Faisal Specialist Hospital & Research Centre (KFSH) is bringing a practical provider-transformation message during its participation at...
Six Regional Organisations Sign MoU to Strengthen Asia’s Dengue Response as Cases Rise
Announced at the 9th Asia Dengue Summit in conjunction with ASEAN Dengue Day and the first WHO-recognised World Dengue Day, the MoU establishes a regional...
APP Group Highlights the Role of Sustainable Products for Hospitality and F&B Ahead of World Cup 2026
ORANGE, Calif., June 15, 2026 /PRNewswire/ — APP Group highlights the growing role of sustainable paper-based products for hospitality and food and beverage businesses as...
ONLYOFFICE DocSpace 3.7 released: AI file generation, smarter forms, and updated editors
SINGAPORE, June 15, 2026 /PRNewswire/ — ONLYOFFICE releases DocSpace 3.7, the newest version of its room-based collaboration platform. A major update adds new AI capabilities,...
Bambusa Therapeutics Presents Positive Preliminary Multiple Ascending Dose Phase 1 Data for BBT002 at the European Academy of Allergy & Clinical Immunology (EAACI) Annual Congress 2026
– BBT002 is a next-generation, long-acting bispecific antibody targeting two clinically and commercially validated targets, IL-4Rα and IL-5 – – BBT002 demonstrated rapid, deep, and...
Tradr Brings Double Long and Short Leverage to SpaceX
Tradr ETFs launched SPCM and SPCG, providing traders with 200% leveraged long and short exposure to SpaceX, one of the most anticipated IPOs in market...
